Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

This systematic review and dose-response meta-analysis aimed to evaluate the association between serum vitamin D status and chronic kidney disease (CKD) progression.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Systematic review.

Systematic review

Uses explicit methods to identify, assess and summarise research on a defined question.

Meta-analysis reported · Blinding not applicable to this review · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

We performed a random-effects meta-analysis to calculate the pooled odds ratio (OR) for CKD progression.

Source: Abstract.

This systematic review and meta-analysis evaluated the association between vitamin D deficiency and CKD progression.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Association between vitamin D deficiency and chronic kidney disease progression

Systematic review · Medicine · 2026

Original publication title

Association between vitamin D deficiency and chronic kidney disease progression

Sayed Yousef Mojtahedi; Mohsen Sedighiyan; Paniz Pourpashang

Copyright © 2026 the Author(s). Published by Wolters Kluwer Health, LLC.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Lower serum 25(OH)D levels were associated with higher odds of CKD progression. However, the observational nature of the evidence does not establish that routine screening or vitamin D supplementation can prevent renal function decline. Prospective studies and randomized trials are needed to clarify the clinical utility of vitamin D assessment and supplementation for renal outcomes.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

This systematic review and dose-response meta-analysis aimed to evaluate the association between serum vitamin D status and chronic kidney disease (CKD) progression.

Source: Background:

Abstract: What methods does the paper describe?

We searched PubMed, Scopus, Web of Science, and Embase for relevant observational and cohort studies published between 1990 and 2024. Eligible studies reported baseline vitamin D levels and CKD progression outcomes. We performed a random-effects meta-analysis to calculate the pooled odds ratio (OR) for CKD progression. A dose-response meta-analysis examined the relationship between serum 25-hydroxyvitamin D (25(OH)D) levels and risk, while subgroup analyses explored follow-up duration, study quality, and comorbid conditions. We assessed evidence certainty using the Grading of Recommendations Assessment, Development and Evaluation approach.

Source: Methods:

Abstract: Results

Eleven studies met the inclusion criteria. The pooled analysis suggested that vitamin D deficiency was associated with 33% higher odds of CKD progression (OR = 1.33, 95% confidence interval [CI]: 1.06 to 1.67; P = .019); however, between-study heterogeneity was considerable (I-squared heterogeneity statistic [I2] = 98.2%). The pooled estimate should therefore be interpreted cautiously as an average association across heterogeneous studies. A dose-response analysis of 10 studies suggested higher odds of CKD progression per 10 ng/mL lower 25(OH)D concentration (OR = 1.18, 95% CI: 1.09 to 1.25), although its interpretation was limited by reconstructed category-level exposure values.

Subgroup analyses showed stronger associations in studies with long-term follow-up (≥5 years; OR = 2.07, 95% CI: 1.29 to 3.14; P = .001) and high-quality studies (OR = 1.35, 95% CI: 1.06 to 1.69; P = .03). The Grading of Recommendations Assessment, Development and Evaluation assessment rated the certainty of evidence as very low for the overall association and low for the dose-response analysis, primarily because of the observational study designs and substantial between-study heterogeneity.

Source: Results:

Abstract: Conclusion

Lower serum 25(OH)D levels were associated with higher odds of CKD progression. However, the observational nature of the evidence does not establish that routine screening or vitamin D supplementation can prevent renal function decline. Prospective studies and randomized trials are needed to clarify the clinical utility of vitamin D assessment and supplementation for renal outcomes.

Source: Conclusion:
Authors’ abstract

Background:

This systematic review and dose-response meta-analysis aimed to evaluate the association between serum vitamin D status and chronic kidney disease (CKD) progression.

Methods:

We searched PubMed, Scopus, Web of Science, and Embase for relevant observational and cohort studies published between 1990 and 2024. Eligible studies reported baseline vitamin D levels and CKD progression outcomes. We performed a random-effects meta-analysis to calculate the pooled odds ratio (OR) for CKD progression. A dose-response meta-analysis examined the relationship between serum 25-hydroxyvitamin D (25(OH)D) levels and risk, while subgroup analyses explored follow-up duration, study quality, and comorbid conditions. We assessed evidence certainty using the Grading of Recommendations Assessment, Development and Evaluation approach.

Results:

Eleven studies met the inclusion criteria. The pooled analysis suggested that vitamin D deficiency was associated with 33% higher odds of CKD progression (OR = 1.33, 95% confidence interval [CI]: 1.06 to 1.67; P = .019); however, between-study heterogeneity was considerable (I-squared heterogeneity statistic [I2] = 98.2%). The pooled estimate should therefore be interpreted cautiously as an average association across heterogeneous studies. A dose-response analysis of 10 studies suggested higher odds of CKD progression per 10 ng/mL lower 25(OH)D concentration (OR = 1.18, 95% CI: 1.09 to 1.25), although its interpretation was limited by reconstructed category-level exposure values.

Subgroup analyses showed stronger associations in studies with long-term follow-up (≥5 years; OR = 2.07, 95% CI: 1.29 to 3.14; P = .001) and high-quality studies (OR = 1.35, 95% CI: 1.06 to 1.69; P = .03). The Grading of Recommendations Assessment, Development and Evaluation assessment rated the certainty of evidence as very low for the overall association and low for the dose-response analysis, primarily because of the observational study designs and substantial between-study heterogeneity.

Conclusion:

Lower serum 25(OH)D levels were associated with higher odds of CKD progression. However, the observational nature of the evidence does not establish that routine screening or vitamin D supplementation can prevent renal function decline. Prospective studies and randomized trials are needed to clarify the clinical utility of vitamin D assessment and supplementation for renal outcomes.

Publication and source details

Original title: Association between vitamin D deficiency and chronic kidney disease progression

Sayed Yousef Mojtahedi; Mohsen Sedighiyan; Paniz Pourpashang

Medicine · 2026

* Correspondence: Paniz Pourpashang, Department of Pediatric Nephrology, School of Medicine, Bahrami Hospital, Tehran University of Medical Sciences, Ansar alHosein st, kiaee ave, Damavand st, Tehran 1641744991, Iran (e-mail: Paaniz.P@gmail.com).Copyright © 2026 the Author(s). Published by Wolters Kluwer Health, LLC.2026https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-08T12:11:29+00:00

DOI: 10.1097/md.0000000000050522 · PMC13549525